INTERNATIONAL PATENT: INSTITUT CURIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PARIS CITE FILES APPLICATION FOR "BIOMARKERS FOR IDENTIFYING PATIENTS HAVING TUMORS WITH HOMOLOGOUS RECOMBINATION DEFICIENCY"

GENEVA, June 2 -- INSTITUT CURIE (26 rue d'Ulm75005 PARIS), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 PARIS), UNIVERSITE PARIS CITE (85 Boulevard Saint-Germain75006 PARIS) filed a patent application (PCT/EP2024/083118) for "BIOMARKERS FOR IDENTIFYING PATIENTS HAVING TUMORS WITH HOMOLOGOUS RECOMBINATION DEFICIENCY" on Nov 21, 2024. With publication no. WO/2025/109076, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAMY-PETIT, Anne-Sophie (6 avenue Rubens78400 CHATOU), REYAL, Fabie...